2896 - Oral PrEP Uptake among HVTN 704/HPTN 085 Participants: Implications for the Future of Biomedical HIV Prevention Trials

Saturday, October 14, 2023

2:09 PM – 2:21 PM US ET

Location: 252 AB

Presenting Author(s)

Valeria D. Cantos, MD (he/him/his)

Associate Professor
Emory University
Atlanta, GA, United States

Slides

Co-Author(s)

MN

Moni Neradilek, MS

Statistical Research Associate
SCHARP (Fred Hutch Cancer Center)
Seattle, Washington, United States
KG

Kevin Gillespie, MS

Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
YH

Yunda Huang, PhD

Fred Hutch
Seattle, Washington, United States
Ad

Allan C. deCamp, Ph.D

Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
SK

Shelly T. Karuna, MD, MPH

Greenlight Bioscience
Seattle, Washington, United States
SE

Srilatha Edupuganti, MD MPH FIDSA

Associate Professor
Emory University School of Medicine
Decatur, GA, United States
Carlos del Rio, MD

Professor of Medicine
Emory University School of Medicine, Division of Infectious Diseases
Decatur, GA, United States
VV

Valdilea Veloso, Ph.D

Instituto Nacional de Infectologia Evandro Chagas-Fiocruz
Rio de Janeiro, Rio de Janeiro, Brazil
MC

Myron S. Cohen, MD

University of North Carolina
Chapel Hill, North Carolina, United States
DD

Deborah J. Donnell, Ph.D

Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
LC

Lawrence Corey, MD

President and Director Emeritus
Fred Hutchinson Cancer Research Center
Seattle, WA, United States
AR

Alison C. Roxby, MD, MSc

Associate Professor
University of Washington
Seattle, Washington, United States
Colleen F. Kelley, MD, MPH (she/her/hers)

Associate Professor of Medicine
Emory University
Decatur, GA, United States

Disclosure(s):

Carlos del Rio, MD: ACTHIV: Board Member (Ongoing); IAS-USA: Board Member (Ongoing); Mass Medical Society/NEJM: Section Chief, JournalWatch Infectious Diseases (Ongoing); Resverlogix: Advisor/Consultant (Ongoing)

Colleen F. Kelley, MD, MPH: Gilead Sciences: Grant/Research Support (Ongoing); Humanigen: Grant/Research Support (Ongoing); Moderna, Inc.: Grant/Research Support (Ongoing); Novavax, Inc: Grant/Research Support (Ongoing); Viiv Healthcare: Grant/Research Support (Ongoing)